S100A14 is a novel independent prognostic biomarker in the triple‐negative breast cancer subtype

Triple‐negative breast cancer (TNBC) represents a heterogeneous subgroup with generally poor outcome and lack of an effective targeted therapy. Prognostic or predictive biomarkers to guide treatment decisions for this group of patients are needed. To evaluate the potential of S100A14 protein as a no...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2015-11, Vol.137 (9), p.2093-2103
Hauptverfasser:	Ehmsen, Sidse, Hansen, Lea Tykgaard, Bak, Martin, Brasch‐Andersen, Charlotte, Ditzel, Henrik J, Leth‐Larsen, Rikke
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Biomarkers, Tumor - metabolism Breast cancer Calcium-Binding Proteins - metabolism Cancer Carcinoma, Ductal, Breast - metabolism Carcinoma, Ductal, Breast - mortality Carcinoma, Ductal, Breast - pathology Cell Line, Tumor Female Humans Kaplan-Meier Estimate Lymphatic system Medical research metastasis Middle Aged Multivariate analysis Pilot Projects Prognosis prognostic marker Protein expression Proteins Retrospective Studies S100A14 Triple Negative Breast Neoplasms - metabolism Triple Negative Breast Neoplasms - mortality Triple Negative Breast Neoplasms - pathology triple‐negative breast cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!